Skip to main content

READDI, not Reactive

For decades, scientists warned of the potential for a global coronavirus outbreak. But when SARS-CoV-2 emerged, no therapeutics, drugs, or vaccines were readily available. The Rapidly Emerging Antiviral Drug Discovery Initiative (READDI) — founded by researchers at UNC and the Structural Genomics Consortium — is not only finding solutions to the COVID-19 pandemic, but also drugs and therapeutics for future viral outbreaks.

COVID-19 Amplifies Issues in Meat Processing Industry

Historically, essential workers in the meat and poultry processing industry have faced difficulties and exploitation, and the COVID-19 pandemic is only intensifying these issues, reports UNC College of Arts & Sciences anthropology professor Angela Stuesse.

The Beaufort Wastewater Treatment Plant

Using Wastewater to Detect, Learn More About COVID-19

North Carolina is one of just eight states that is funneling its wastewater data to the federal government to track coronavirus. Leading the charge for N.C. is UNC marine scientist Rachel Noble, who launched a wastewater surveillance system last year to help public officials detect and understand COVID-19 in their communities.

UNC Health Gives First COVID-19 Vaccines

Medical workers at the UNC Medical Center in Chapel Hill began receiving COVID-19 vaccines Dec. 15, marking a significant turning point in the response to the pandemic.

Carolina Tracker with a map of NC COVID-19 cases

Researchers Launch COVID-19 Data Tracker

On December 7, a team of UNC researchers launched a website called Carolina Tracker: A Resource for Recovery, which includes a dashboard to track indicators across different domains such as employment and the economy, travel patterns, real estate, and society.

a person administers a shot to someone's arm

Blalock Develops COVID-19 Vaccine Tracking Website

To improve transparency surrounding COVID-19 vaccine development, UNC Eshelman School of Pharmacy Professor Emeritus Susan Blalock has developed a website that provides accurate and up-to-date information about ongoing, late-stage clinical trials.

What We Do and Don’t Know About the COVID-19 Vaccines

With a continued surge in COVID-19 cases in the U.S. and around the world, clinical trials are showing some vaccines are 95 percent effective. UNC Health infectious disease expert Cindy Gay, who leads the Moderna clinical trial at Carolina, shares what scientists do and don’t know about these vaccines.

open sign on a store window

Support for Local Businesses During the Pandemic

A team of experts from the UNC Gillings School of Global Public Health has created a new initiative and research study to provide free technical assistance and recommendations to help reduce local business’ exposure to COVID-19.

The Science Behind COVID-19 Safety Measures

A UNC Health professor shares insights gained from scientists’ nine months of non-stop research on COVID-19. Learn more about how the virus is transmitted and the science behind why wearing masks and social distancing can help prevent its spread.

Before the Holidays, Get Tested For COVID-19

In addition to getting tested for COVID-19 before traveling for the holidays, UNC experts advise people to monitor themselves for symptoms and adhere to the three Ws — wearing a mask, waiting 6 feet apart from others and washing your hands.